Quantum Leap Healthcare Collaborative™ is a 501C(3) charitable organization integrating high-impact clinical research with patient care to improve and save lives.

PORTFOLIO

Learn more about our projects

I-SPY Trials

Developing new cancer treatments faster and for less

BreastCancerTrials.org

Personalized matching to breast cancer clinical trials

CTMatch

Customizing trial matching to other diseases

OneSource

Radically streamling collection and distribution of data

I-SPY COVID

Focusing on the Problem with an Important New Solution

Visit the I-SPY website for more information.

Latest News

July 30, 2020

The COVID R&D Alliance and Quantum Leap Healthcare Enroll First Patients in I-SPY COVID Trials

June 8, 2020

Quantum leap selects Sanofi's SAR439859 as the Oral SERD in the Endocrine Optimization Pilot

May 27, 2020

Quantum Leap Healthcare Selects Aerpio's Razuprotafib for I-SPY COVID Trial for ARDS patients

July 30, 2020

The COVID R&D Alliance and Quantum Leap Healthcare Enroll First Patients in I-SPY COVID Trials

August 7, 2019

KEYTRUDA’s Success in TNBC Validates I-SPY 2 Adaptive Approach to Phase II Trials

February 15, 2019

Esserman among bioscience leaders profiled in SF Business Times